No Detail Found!

Rheumatoid Arthritis: Patient Characteristics Activities at Tertiary Hospital in Saudi Arabia and Disease

Author(s)
Sami M. Bahlas Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah, 21589, Saudi Arabia
Yasser M. Bawazir Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah, 21589, Saudi Arabia
Abdullah M. Alagha Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah, 21589, Saudi Arabia
Shahad A. Kenany Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah, 21589, Saudi Arabia
Maan M. Almaghrabi Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah, 21589, Saudi Arabia
Rafah M. Ghazi Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah, 21589, Saudi Arabia
Abstract
Background: The systemic autoimmune disease rheumatoid arthritis (RA) is characterized by extra-articular disorders and persistent inflammation of the synovial joints. Rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (ACPA) are autoantibodies that are important for diagnosis and prognosis. Treat-to-target guidelines place a strong emphasis on reaching remission or decreased disease activity but they ignore patient characteristics or potential future disease behavior. Aim: To evaluate comparison between RA patients' demographics, medication use and the disease activity at a tertiary hospital in Jeddah, Saudi Arabia. Materials and Methods: This retrospective study includes 259 patients with RA aged =18 who meet ACR/EULAR 2010 criteria. Data collected from electronic medical records at King Abdulaziz University hospital (KAUH) between December 2021 and December 2023. Demographics, clinical characteristics, medication history and laboratory data for RF, Anti-Nuclear Antibodies (ANA) and ACPA levels were recorded. Disease activity was assessed using clinical disease activity index (CDAI) or disease activity score in 28 joints (DAS28) -Erythrocyte sedimentation. Results: The study involved 259 participants, primarily female, married and college students. There were insignificant differences between disease activity, gender, education, job, marital status, having kids, body mass index (BMI), RF and ACPA. Biologic disease-modifying anti-rheumatic medicines (DMARDs) showed insignificant changes with disease severity but rituximab showed moderate disease severity and infliximab showed more patients with remission. Non-biologic DMARDs, including Leflunomide and Hydrochloroquine, showed low to moderate disease activity. Targeted synthetic DMARDs, notably baricitinib and upadacitinib, dramatically alter disease activity. Conclusion: The study revealed that infliximab showed higher remission rates and rituximab showed moderate activity. Leflunomide, hydrochloroquine, baricitinib and upadacitinib exhibited low to moderate disease activity. Medical professionals should evaluate infliximab's efficacy in achieving remission and consider positive ANA. Further research is needed to confirm these findings and investigate additional factors.
Publication Details
Page(s) 1-9
Published Journal: Journal of Pioneering Medical Sciences, Volume: 14, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
Disease, Rheumatoid Arthritis, Demographic characteristics, Saudi Arabia, Rheumatoid factor, biologic disease-modifying anti-rheumatic medicines (DMARDs), treatment efficacy, Anti-cyclic citrullinated peptide antibody (ACPA), clinical disease activity index (CDAI), disease activity score in 28 joints (DAS28)
References
Tomar ,Rajat K. De. ,K. De and Namrata Tomar .2014 .A Brief Outline of the Immune System. , (8) : 1-12.
Xu ,Qian .2021 .Causal relationship between gut microbiota and autoimmune diseases: A two-sample mendelian randomization study. ”Frontiers in Immunology, 746998 : .
Singh Jasvinder A.,November 2015 . .2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis. ” Arthritis Rheumatology, 68(1) : 1-26.
Reed George W.,April George W. .2017 .Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritis. ” Arthritis Research and Therapy, 19(1) : .
Tancer ,Beth I. Wallace. .2024 .Advances in the medical treatment of rheumatoid arthritis. ” Hand Clinics, 07(1) : 11-23.
Intriago M. .2019 .July 2019. The Scientific World Journal, : .
Alvarez-Nemegyei ,November 2020 .2018 .Association between Overweight/Obesity and Clinical Activity in Rheumatoid Arthritis. Reumatología Clínica, 11(6) : 462-467.
.2022 .Patients with seronegative rheumatoid arthritis have a different phenotype than seropositive patients: A clinical and ultrasound study. ” Frontiers in Medicine, 978351 : .
Fujii ,Takayuki ,January .2024 .Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: Evaluation of 10-year data from the Kurama cohort. ” Arthritis Research & Therapy, 26(1) : .
. .. , : .
Fuchs Howard A. .1989 .A simplified twenty eight-joint quantitative articular index in rheumatoid arthritis. ” Arthritis and Rheumatism, 32(5) : 531-537.
. .. , : .
.2021 .. , 686155 : .
Fraenkel ,Liana . .2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. ” Arthritis and Rheumatology, 73(7) : 1108-1123.
. .. , : .
. .. , : .
. .. , : .
. .. , : 00063030.
. .. , : .
Lopez-Olivo .2015 .Rituximab for rheumatoid arthritis. ” Cochrane Database of Systematic Reviews, : .
. .. , : .
Conigliaro ,Paola .2019 .Challenges in the treatment of rheumatoid arthritis. ” Autoimmunity Reviews, 05(7) : 706-713.
Wang J,April 2012 . .Genome-wide association analysis implicates the involvement of eight loci with response to Tocilizumab for the treatment of rheumatoid arthritis. ” The Pharmacogenomics Journal, 13(3) : 235-241.
.2012 .. , 8 : .
Pearce Glen J.,Ian C.,Chikanza C. . .Targeting tumour necrosis factor in the treatment of rheumatoid arthritis. ” BioDrugs, 15 : .
Prasad ,Peeyush . .Rheumatoid arthritis: Advances in treatment strategies. ”Molecular and Cellular Biochemistry, 478(1) : 69-88.
Santiago T. . .Psychological factors associated with response to treatment in rheumatoid arthritis.” Current Pharmaceutical Design, v o l . 2 1 , n o . 2 , N o v e m b e r 2 0 1 4. , 2 5 7 - 2 6 : 9.
. .. , : .
. .. , : .
0

Citations

0

Downloads

43

Views